MIA joins Sydney Health Partners

MIA joins Sydney Health Partners

22 December 2021

Melanoma Institute Australia (MIA) has joined Sydney Health Partners, becoming the 16th health organisation and 11th Medical Research Institute in the growing Partnership.

MIA is a nationally-affiliated network of melanoma researchers and clinicians based in Sydney at The Poche Centre– the world’s largest melanoma research and treatment facility.

The membership builds on MIA’s existing affiliations with four founding members of Sydney Health Partners - the University of Sydney, and Sydney, Northern Sydney and Western Sydney Local Health Districts.

Sydney Health Partners’ Executive Director, Professor Don Nutbeam, has welcomed MIA, saying “culturally there’s a great fit between Melanoma Institute Australia and what we are aspiring to achieve across the health system with our health partners.”  

“Like MIA, we seek a faster, better fit between the world class research that’s going on across all our Partners, the quality care we are looking to deliver to our patients and the public benefit that we are trying to deliver to wider society.”

 

Co-Medical Director of MIA, Professor Georgina Long AO, says Melanoma Institute Australia shares Sydney Health Partners’ focus on more rapidly translating research evidence into patient benefit.

“You can have great ideas, but you’ve got to test the ideas and ultimately, if the idea is worthwhile and impacts outcomes for patients then you’ve got to make sure that gets introduced to the rest of Australia and the rest of the world.”

According to MIA Co-Medical Director, Professor Richard Scolyer AO, it’s vital that MIA does more than just find answers to the clinical questions that arise when treating patients.

“We are the largest melanoma treatment centre in the world and because of that we see patterns and there are questions that come up that need to be addressed,” he said. “So, when we find answers to those questions, we are committed to implementing changes to get better outcomes for our patients.”

Professor Nutbeam says that while MIA will hopefully benefit from collaborating with a wider community of research translators, the Institute has just as much to offer the Partnership.

“I think that because of their track record and experience they have a fair bit to teach us about how to get this right and get the closest possible connection between outstanding research and great clinical care.”

Sydney Health Partners is accredited by the National Health and Medical Research Council as an Advanced Health Research and Translation Centre.

Commencing operations in 2016 with 14 members, the Partnership subsequently welcomed the Kolling Institute of Medical Research in 2019.

With the addition of Melanoma Institute Australia, Sydney Health Partners is now one of the largest academic health science centres in the world.

Collectively, the Partners provide care to 2.7 million people, representing more than 10 per cent of the Australian population.

Sydney Health Partners’ goal is to demonstrate that new evidence-based interventions can be successfully implemented and scaled-up in large and diverse health systems.

“Since Sydney Health Partners’ establishment, the health system’s need for better research translation has only become more obvious,” said Professor Nutbeam.

“So, we were really delighted when the MIA contacted us to become partners with Sydney Health Partners.

“They exemplify a lot of the things we are trying to get right in our health care system – outstanding world class research being connected to patient care as quickly and efficiently as possible.”

Professors Long and Scolyer describe joining Sydney Health Partners as “a fantastic opportunity to work with people with the breadth of experience, knowledge and skills to have those research findings implemented.”

“To make things happen you need policy, you need energy and you need advocacy – and that can only be done when you bring the right groups of people, with different skills sets, together.”

Read more about Sydney Health Partners here

Women of MIA lead the way in melanoma research at SMR
31 Oct 2018

Women of MIA lead the way in melanoma research at SMR

An impressive contingent of female delegates from Melanoma Institute Australia have presented findings across the whole spectrum of melanoma research at the Society for Melanoma Research 2018 Congress in Manchester, England.

Women of MIA lead the way in melanoma research at SMR
31 Oct 2018

Women of MIA lead the way in melanoma research at SMR - Copy

An impressive contingent of female delegates from Melanoma Institute Australia have presented findings across the whole spectrum of melanoma research at the Society for Melanoma Research 2018 Congress in Manchester, England.

Women of MIA lead the way in melanoma research at SMR
31 Oct 2018

Women of MIA lead the way in melanoma research at SMR - Copy

An impressive contingent of female delegates from Melanoma Institute Australia have presented findings across the whole spectrum of melanoma research at the Society for Melanoma Research 2018 Congress in Manchester, England.

Immune cell research presented at SMR
30 Oct 2018

Immune cell research presented at SMR

Over 800 researchers and clinicians from around the world were welcomed to Manchester for the 15th International Congress of the Society for Melanoma Research (SMR). Melanoma Institute Australia (MIA) has again sent an impressive number of delegates to present both oral presentations and posters with the latest in translational research.

Professor Georgina Long makes history as the first woman and first Australian to lead the Society for Melanoma Research
26 Oct 2018

Professor Georgina Long makes history as the first woman and first Australian to lead the Society for Melanoma Research

Professor Georgina Long makes history as the first woman and first Australian to lead the world’s most prestigious international melanoma research association.

Patients to benefit from updated skin tumour publications
26 Oct 2018

Patients to benefit from updated skin tumour publications

Two publications co-edited by MIA Co-Medical Director Professor Richard Scolyer are now available to healthcare professionals. They aim to provide assistance in the care and management of patients with skin cancer, including melanoma.

SunSafe Student Ambassador Program
25 Oct 2018

SunSafe Student Ambassador Program

Melanoma Institute Australia has introduced a new educational program to teach teenagers about the dangers of melanoma and the importance of sun safety. 

International collaboration the key to increasing survival
24 Oct 2018

International collaboration the key to increasing survival

"International collaboration remains the key to ensuring this pioneering research continues so we can increase survival rates for advanced melanoma patients and move us closer to achieving our goal of zero deaths from melanoma," says Professor Georgina Long, of the clinical trial results presented at ESMO 2018.

High-risk Stage III melanoma patients to benefit from Australia/Netherlands collaboration
23 Oct 2018

High-risk Stage III melanoma patients to benefit from Australia/Netherlands collaboration

Research that could change clinical practice for high-risk Stage III melanoma patients has been presented at the European Society for Medical Oncology (ESMO) Congress in Munich.

Monthly dose of immunotherapy allows flexibility for patients undergoing treatment
11 Oct 2018

Monthly dose of immunotherapy allows flexibility for patients undergoing treatment

A larger, monthly dose of immunotherapy can give melanoma patients more freedom without sacrificing effectiveness.

Australia's best minds in melanoma research converge on Melbourne
08 Oct 2018

Australia's best minds in melanoma research converge on Melbourne

The Australasian Melanoma Conference, hosted by the Australasian Melanoma Conference Committee, was held in Melbourne on the weekend, with many of MIA's clinicians in attendance.

Nobel Prize for novel cancer therapies
04 Oct 2018

Nobel Prize for novel cancer therapies

The two men who discovered checkpoint inhibitors, the brakes of the immune system, were awarded the Nobel Prize in Physiology or Medicine on Monday, October 1.

World Health Organisation launches 4th edition of Classification of Skin Tumours
31 Aug 2018

World Health Organisation launches 4th edition of Classification of Skin Tumours

The World Health Organisation (WHO) is releasing the 4th edition of Classification of Skin Tumours.

Professor John Thompson awarded prestigious 2018 RPA Foundation Research Medal
31 Aug 2018

Professor John Thompson awarded prestigious 2018 RPA Foundation Research Medal

Former Executive Director of Melanoma Institute Australia Professor John Thompson awarded the prestigious 2018 RPA Foundation Research Medal.

Support PBS listing for pembrolizumab
23 Aug 2018

Support PBS listing for pembrolizumab

Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for pembrolizumab.

World Congress on Cancers of the Skin 2018
17 Aug 2018

World Congress on Cancers of the Skin 2018

The World Congress on Cancers of the Skin 2018 has featured many minds from MIA sharing their expertise and wealth of knowledge with over 1000 attendees from around the world.

Melanoma Institute Australia welcomes new CEO Matthew Browne
09 Aug 2018

Melanoma Institute Australia welcomes new CEO Matthew Browne

Melanoma Institute Australia is delighted to announce the appointment of Matthew Browne as Chief Executive Officer (CEO).

Melanoma in Practice: Nurse Conference
26 Jul 2018

Melanoma in Practice: Nurse Conference

It was a full house this week at Melanoma Institute Australia thanks to our ‘Melanoma in Practice: Nurse Conference’. 

Reducing the risk of melanoma in young adults
19 Jul 2018

Reducing the risk of melanoma in young adults

A new study from The University of Sydney shows that sunscreen reduces melanoma risk by 40 per cent when used from a young age.

Melanoma Institute Australia launches free e-learning education portal
20 Jun 2018

Melanoma Institute Australia launches free e-learning education portal

Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.